Independent dose–response associations between fetuin-a and lean nonalcoholic fatty liver disease
Journal
Nutrients
Journal Volume
13
Journal Issue
9
Date Issued
2021-09-01
Author(s)
Abstract
Patients with lean NAFLD make up an increasing subset of liver disease patients. The association between lean NAFLD and feutin-A, which serves as a hepatokine and adipokine, has never been examined. Our study aimed to explore the association of serum fetuin-A among lean and non-lean patients. The study comprised 606 adults from the community, stratified into lean or non-lean (BMI
Subjects
Central obesity | Fetuin-A | Insulin resistance | Lean NAFLD
SDGs
Other Subjects
cholesterol; fetuin A; glucose; high density lipoprotein cholesterol; insulin; low density lipoprotein cholesterol; triacylglycerol; fetuin A; abdominal obesity; abdominal radiography; adult; age; Article; B scan; body fat; body mass; cholesterol blood level; clinical feature; controlled study; current smoker; disease severity; dose response; echography; fasting; female; gender; glucose blood level; homeostasis model assessment; human; insulin level; insulin resistance; interview; lean nonalcoholic fatty liver; major clinical study; male; nonalcoholic fatty liver; protein blood level; quantitative analysis; questionnaire; spectrofluorometry; Taiwan; triacylglycerol blood level; waist circumference; abdominal obesity; blood; insulin resistance; middle aged; nonalcoholic fatty liver; odds ratio; risk factor; statistical model; Adult; alpha-2-HS-Glycoprotein; Body Mass Index; Female; Humans; Insulin Resistance; Logistic Models; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity, Abdominal; Odds Ratio; Risk Factors; Surveys and Questionnaires; Taiwan
Type
journal article